California Institute for Regenerative Medicine: State Stem Cell & Gene Therapy Agency Sets Up Support Program To Help Patients Participate In Clinical Trials
September 30, 2022
September 30, 2022
SAN FRANCISCO, California, Sept. 30 -- The California Institute for Regenerative Medicine issued the following news release on Sept. 29, 2022:
For many patients battling deadly diseases, getting access to a clinical trial can be life-saving, but it can also be very challenging. Today the governing Board of the California Institute for Regenerative Medicine (CIRM) approved a concept plan to make it financially and logistically easier for patients to take part in CIRM-funded clinical . . .
For many patients battling deadly diseases, getting access to a clinical trial can be life-saving, but it can also be very challenging. Today the governing Board of the California Institute for Regenerative Medicine (CIRM) approved a concept plan to make it financially and logistically easier for patients to take part in CIRM-funded clinical . . .